Clinical study for management of supportive treatment for high-dose chemotherapy with peripheral blood stem cell transplantation (PBSCT) for intractable testicular tumor

Acta Urologica Japonica

Volumn 52, Issue 7, 2006, Pages 531-536

  Shigemura, Katsumi ^a   Tanaka, Kazushi ^a   Hara, Isao ^a   Muramaki, Mototsugu ^a   Arakawa, Soichi ^a   Fujisawa, Masato ^a  

^a KOBE UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

High dose chemotherapy; Supportive care; Testicular tumor

Indexed keywords

ANTINEOPLASTIC AGENT; BLEOMYCIN; CARBOPLATIN; CISPLATIN; ETOPOSIDE; IFOSFAMIDE; BEP PROTOCOL; ICE PROTOCOL 1;

ADULT; AGED; AGRANULOCYTOSIS; ARTICLE; BONE MARROW SUPPRESSION; CHEMOTHERAPY; CLINICAL ARTICLE; CLINICAL ASSESSMENT; CONTROLLED STUDY; DRUG DOSE REGIMEN; HISTOLOGY; HUMAN; LEUKOCYTE COUNT; MALE; OPPORTUNISTIC INFECTION; PALLIATIVE THERAPY; PERIPHERAL BLOOD STEM CELL TRANSPLANTATION; PREVENTIVE MEDICINE; SEPSIS; TESTIS TUMOR; ADOLESCENT; DRUG ADMINISTRATION; INFECTION CONTROL; MIDDLE AGED; MULTIMODALITY CANCER THERAPY; SEMINOMA;

ADOLESCENT; ADULT; AGED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BLEOMYCIN; CISPLATIN; COMBINED MODALITY THERAPY; DRUG ADMINISTRATION SCHEDULE; ETOPOSIDE; HUMANS; IFOSFAMIDE; INFECTION CONTROL; MALE; MIDDLE AGED; OPPORTUNISTIC INFECTIONS; PERIPHERAL BLOOD STEM CELL TRANSPLANTATION; SEMINOMA; TESTICULAR NEOPLASMS;

EID: 33748451138     PISSN: 00181994     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (15)

1. Motzer RJ, Mazumdar M, Bosl GJ, et al.: High-dose carboplatin, etoposide, and cyclophosphamide for patients with refractory germ cell tumors: treatment results and prognostic factors for survival and toxicity. J Clin Oncol 14: 1098-1105, 1996
2. Nichols CR, Andersen J, Lazarus HM, et al.: High-dose carboplatin and etoposide with autologous bone marrow transplantation in refractory germ cell cancer: an Eastern Cooperative Oncology Group protocol. J Clin Oncol 10: 558-563, 1992
3. Motzer RJ, Gulati SC, Crown JP, et al.: High-dose chemotherapy and autologous bone marrow rescue for patients with refractory germ cell tumors: early intervention is better tolerated. Cancer 69: 550-556, 1992
4. Bokemeyer C and Schmoll HJ: Treatment of advanced germ cell tumours by dose intensified chemotherapy with haematopoietic growth factors or peripheral blood stem cells (PBSC). Eur Urol 23: 223-230, 1993
5. Henon PR, Liang H, Beck-Wirth G, et al.: Comparison of hematopoietic and immune recovery after autologous bone marrow or blood stem cell transplants. Bone Marrow Transpl 9: 285-291, 1992
6. Siegert W, Beyer J, Strohscheer I, et al.: High-dose treatment with carboplatin, etoposide, and ifosfamide followed by autologous stem-cell transplantation in relapsed or refractory germ cell cancer: a phase I/II study. The German Testicular Cancer Cooperative Study Group. J Clin Oncol 12: 1223-1231, 1994
7. Motzer RJ, Mazumdar M, Bajorin DF, et al.: High-dose carboplatin, etoposide, and cyclophosphamide with autologous bone marrow transplantation in first-line therapy for patients with poor-risk germ cell tumors. J Clin Oncol 15: 2546-2552, 1997
8. Nakagawa S, Miki T, Akaza H, et al.: High-dose chemotherapy with peripheral blood stem cell autotransplantation for patients with poor-risk testicular germ cell tumors-pilot study of the Japan Blood Cell Transplantation Study Group. Hinyokika Kiyo 45: 805-809, 1999
9. Yamada Y, Hara I, Gohji K, et al.: Recovery of leukocyte function after super-high-dose chemotherapy with peripheral blood stem cell transplantation in testicular cancer patients. Int J Cancer 72: 39-42, 1997
10. Hara I, Yamada Y, Miyake H, et al.: Clinical outcome of high-dose chemotherapy combined with peripheral blood stem cell transplantation for male germ cell tumors. Anti-cancer Drug 10: 711-718, 1999
11. International Germ Cell Consensus Classification: a prognostic factor-based staging system for metastatic germ cell cancers. International Germ Cell Cancer Collaborative Group. J Clin Oncol 15: 594-603, 1997
12. Albers P, Albrecht W, Algaba F, et al.: Guidelines on testicular cancer. Eur Urol 48: 885-894, 2005
13. Hughes WT, Armstrong D, Bodey GP, et al.: 2002 guidelines for the use of antimicrobial agents in neutropenic patients with cancer. Clin Infect Dis 15: 730-751, 2002
14. Guideline for preventing Opportunistic Infections Among Hematopoitic Stem Cell Transplant Recipients (Recommendations of CDC, the Infectious Diseases Society of America, and the American Society of Blood and Marrow Transplantation) CDC Morb Mortal Wkly Rep 49: RR-10, 2000
15. Masaoka T: Evidence-based recommendations for antimicrobial use in febrile neutropenia in Japan: excutive summary. Clin Infect Dis 39: S49-52, 2004